Urgent coronary bypass surgery for failed percutaneous coronary intervention in the stent era: Is backup still

S J Shubrooks1, R W Nesto, D Leeman

  • 1Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass., USA. sshubroo@caregroup.harvard.edu

Insights

Urgent coronary bypass surgery (UCABG) after percutaneous coronary intervention (PCI) is rare and unpredictable. Stenting does not eliminate the need for surgical backup, as patients remain unstable.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Surgical Outcomes

Background:

  • Current guidelines mandate on-site surgical backup for percutaneous coronary intervention (PCI) in the US.
  • The decreasing frequency of urgent coronary bypass surgery (UCABG) with newer technologies raises questions about the continued necessity of this backup.

Purpose of the Study:

  • To evaluate the necessity of on-site surgical backup for percutaneous coronary intervention (PCI) in light of evolving technologies and decreasing rates of urgent coronary bypass surgery (UCABG).

Main Methods:

  • Analysis of a database of 5655 patients undergoing PCI between 1992 and 1997.
  • Outcomes and patient characteristics were assessed across four time periods, including the introduction of coronary stenting.

Main Results:

  • The frequency of UCABG for failed PCI decreased from 2.2% to 0.6%, with no significant change in in-hospital death or myocardial infarction rates.
  • Coronary stenting increased to 72% but did not reliably prevent UCABG; only 30% of UCABG patients had stenting-amenable lesions, and stenting was unsuccessful in these cases.
  • Even with advanced interventions, only 40% of patients requiring UCABG were stable upon transfer to the operating room.

Conclusions:

  • Despite low rates, UCABG for failed PCI remains unpredictable and necessary due to patient instability.
  • Coronary stenting does not eliminate the need for surgical standby, and readily available surgical backup is crucial for this high-risk patient group.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...